Improve automation control and inspection levels in the pharmaceutical industry
GMP requires that the production of pharmaceuticals should be continuous, and the time of process delivery is short. Therefore, the old-style decentralized operation and the man-machine-based equipment with a large proportion of experience need to be improved in terms of reducing transmission turnover, spacing, reducing contact between humans and drugs, and shortening the exposure time of drugs. The increase in the level of automation is an important factor in reducing errors due to manual operations during production.
At present, in the quality inspection process of many drugs, China still stays at the original level of manual visual inspection, which is very different from the foreign level. In the powder needle test, each visual inspector checks at least 120 bottles per minute, and the results of human detection are different for various reasons, and it is difficult to ensure the reliability of the visual inspection. Obviously, this type of testing simply does not meet the FDA requirements for traceability and accountability. Therefore, domestic pharmaceutical equipment factories should pay attention to this part and increase the intensity of research and development. With the promotion of PAT (ProcessAnalytical Technology) by FDA, online detection and monitoring will also be the trend of the times. This momentum is also evident from the high-profile participation of automation giants such as Siemens, Rockwell and ABB in ChinaPharm last year.
/
Kn95 Face Mask,Disposable Kn95 Face Mask,Kn95 Respirator,Kn95 Particulate Respirator
Jiangyin Huashi Medical Equipment Co.,Ltd , https://www.medicalwellcare.com